Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexandra Dardac"'
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed to improve outcomes in such patients. B-cell maturation antigen (BCMA) has become an important thera
Externí odkaz:
https://doaj.org/article/d78ef0342e26469095585ae9953d6d45
Publikováno v:
Therapeutic Advances in Hematology
Therapeutic Advances in Hematology, Vol 12 (2021)
Therapeutic Advances in Hematology, Vol 12 (2021)
Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed to improve outcomes in such patients. B-cell maturation antigen (BCMA) has become an important thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb75bd5405a545623a59a35bf830b0a
https://pubmed.ncbi.nlm.nih.gov/33796236
https://pubmed.ncbi.nlm.nih.gov/33796236
Autor:
Swathi Namburi, Alexandra Dardac, C. Anthony Blau, Francis M. Senecal, Shaji Kumar, Kenneth C. Anderson, Paul G. Richardson, William I. Bensinger, Elora Mallick, Grace Nam, Sibel Blau, Ricardo Lopez Barquilla, Andrew J. Cowan, Jennifer Wren, Cheng Zheng, Joshua Richter, Leena Chhun, Jayne Piboonvaranggoon
Publikováno v:
Blood. 136:43-44
Background: Here we describe an online network of patients with cancer, clinicians and researchers, layered on top of a comprehensive real world database of treatments and outcomes, continuously updated in near real time, and initially focused on mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b21d8aeefb91d6df88e49481ee97ed9c
https://doi.org/10.1182/blood-2020-138705
https://doi.org/10.1182/blood-2020-138705